NanoCor Therapeutics
ID: 5291367A biotechnology company developing intracellular genetic protein therapy to treat chronic heart failure
3
Funding Rounds
$17.6m
Money raised
Recent Funding Rounds
Overview
A biotechnology company developing intracellular genetic protein therapy to treat chronic heart failure
- Websites:
- Business model: B2B
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Sh**** Mi***** |
|
- | linkedin twitter facebook instagram |
Funding series
Funding Series Analysis
The company NanoCor Therapeutics has raised a total of $3.75m in funding over 3 rounds.
Key Insights:
- NanoCor Therapeutics funding round, September 2007: $3.75m
- NanoCor Therapeutics Series B round, September 2007: $6.3m
- NANOCOR THERAPEUTICS INC funding round, June 2009: $7.5m
Industries
NanoCor Therapeutics is active in the following industries: